Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 2, 2007, Pages 145-152

  Shovman, O ^a   Gilburd, B ^a   Barzilai, O ^a   Langevitz, P ^a,b   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti beta2 glycoprotein I (anti 2GPI); Antibodies; Anticardiolipin (aCL); Antiphospholipid syndrome (APS); Manifestations

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEDICAL LITERATURE; PATHOGENESIS; PREGNANCY DISORDER; PROTEIN ANALYSIS; REVIEW; THROMBOSIS;

ABORTION, HABITUAL; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY DISEASES; NERVOUS SYSTEM DISEASES; PREGNANCY; THROMBOCYTOPENIA; THROMBOSIS;

EID: 35348914713     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0001-3     Document Type: Review

References (78)

1. Hughes GR (1983) Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 287:1088-1089
2. Shoenfeld Y (2003) Systemic antiphospholipid syndrome. Lupus 12:497-498
3. Arvieux J, Roussel B, Jacob MC, Colomb MG (1991) Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 143:223-229
4. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 42:1309-1311
5. Li Z, Krilis SA (2003) Anti-beta(2)-glycoprotein I antibodies and the antiphospholipid syndrome. Autoimmun Rev 2:229-234
6. Blank M, Faden D, Tincani A et al (1994) Immunization with anticardiolipin cofactor (beta 2 GP-I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 7:441-455
7. Blank M, Krause I, Fridkin M et al (2002) Bacterial induction of autoantibodies to beta 2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 109:797-804
8. Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR (1997) The antiphospholipid/cofactor syndromes. 2. A Variant in patients with systemic lupus erythematosus with antibodies to beta(2)-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 24:1545-1551
9. 2-glycoprotein I: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J Rheumatol 25:2131-2134
10. 2-glycoprotein I antibodies: A marker of antiphospholipid syndrome? Lupus 4:122-130
11. Arvieux J, Roussel B, Colomb MG (1994) Anticorps antiphospholipid et anti-beta2-gpI. Ann Biol Clin (Paris) 52:381-385
12. Tincani A, Balestrieri G, Spatola L, Cinquini M, Meroni PL, Roubey RA (1998) Anticardiolipin and anti-beta 2glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome. Clin Exp Rheumatol 16:396-402
13. Levine JS, Branch DW, Rauch J (2002) Medical Progress: The aniphospholipid syndrome. N Engl J Med 346:752-763
14. Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-beta2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717-2723
15. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 101:1827-1832
16. Locht H, Wiik A (2006) IgG og IgM isotypes of anti-cardiolipin and anti Beta2-glycoprotein-I antibodies reflect different forms of recent thrombo-embolic events. Clin Rheumatol 25:246-250
17. Galli M (2004) Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Thromb Res 114:597-601
18. Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME et al (1999) Elevated anticardiolipin antibody titre is a stroke risk factor in a multiethnic population independent of Iso type of degree of positivity. Stroke 30:1561-1565
19. Verro P, Levine SR, Tietjen GE (1998) Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29:2245-2253
20. Szczepanski M, Cieslak E, Gardas A, Bauer A, Majkowski J (1998) Prevalence of high IgM anticardiolipins in patients with ischemic stroke. Eur J Neurol 5:287-290
21. Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: An incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31:1289-1293
22. Samarkos M, Davies KA, Gordon C, Loizou S (2006) Clinical significance of IgA anticardiolipin and anti-beta(2)-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rheumatol 25:199-204
23. Lopez LR, Santos ME, Espinoza LR, La Rosa FG (1992) Clinical significance of immunogloublin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus: Correlations with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 98:449-454
24. Cucurull E, Espinoza LR, Mendez E et al (1999) Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards. Lupus 8:134-141
25. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Koike T (1998) IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol 25:74-78
26. Lee SS, Cho ML, Joo YS et al (2001) Isotypes of anti-β2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol 28:520-524
27. Tsutsumi A, Koike T, Ichikawa K et al (1988) IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus. J Rheumatol 15:1764-1767
28. Sammaritano LR, Ng S, Sobel R et al (1997) Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 40:1998-2006
29. Hamilton RG (1987) Hamilton RG: Human IgG subclass measurements in the clinical laboratory. Clin Chem 33:1707-1725
30. Skvaril F (1986) IgG subclasses in viral infections. Monogr Allergy 19:134-143
31. Samarkos M, Davies KA, Gordon C, Walport MJ, Loizou S (2001) IgG subclass distribution of antibodies against beta (2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations. Rheumatology (Oxford) 40:1026-1032
32. Meroni PL, Riboldi P (2001) Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 13:377-382
33. Pierangeli SS, Gharavi AE, Harris EN (2000) Experimental thrombosis and antiphospholipid antibodies: new insights. J Autoimmun 15:241-247
34. Shoenfeld Y, Sherer Y, Blank M (1998) Antiphospholipid syndrome in pregnancy-animal models and clinical implications. Scand J Rheumatol Suppl 107:33-36
35. Blank M, Cohen J, Toder V, Shoenfeld Y (1991) Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Natl Acad Sci USA 15:3069-3073
36. Meroni PL, di Simone N, Testoni C, D'Asta M, Acaia B, Caruso A (2004) Antiphospholipid antibodies as cause of pregnancy loss. Lupus 13:649-652
37. Faden D, Tincani A, Tanzi P, Spatola L, Lojacono A, Tarantini M, Balestrieri G (1997) Anti-beta 2 glycoprotein I antibodies in a general obstetric population: Preliminary results on the prevalance and correlation with pregnancy outcome. Anti-beta 2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 73:37-42
38. Marai I, Tincani A, Balestrieri G, Shoenfeld Y (2005) Anticardiolipin and anti-beta-glycoprotein-I antibodies. Autoimmunity 38:33-38
39. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW (1996) Antiphospholipid antibodies and fetal death. Obstet Gynecol 87:489-493
40. Gris JC, Perneger TV, Quere I et al (2003) Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 102:3504-3513
41. Gris JC, Quere I, Sanmarco M et al (2000) Antiphospholipid and antiprotein syndromes in nonthrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss: The Nîmes Obstetricians and Haematologists Study - NOHA. Thromb Haemost 84:228-236
42. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus. A prospective study of 103 pregnancies. Rheumatology (Oxford) 41:643-650
43. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO (1997) Relationship of anti-beta-2-glycoprotein-I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 78:1008-1014
44. Lynch A, Byers T, Emlen W, Rynes D, Shetterly SM, Hamman RF (1999) Association of antibodies to beta 2-glycoprotein I with pregnancy loss pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Obstet Gynecol 93:193-198
45. Ailus K, Tulppala M, Palosuo T, Ylikorkala O, Vaarala O (1996) Antibodies to beta-2-glycoprotein and prothrobin in habitual abortion. Fertil Steril 66:937-941
46. Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R (2005) Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 129:61-68
47. Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T (2006) A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction 131:817-822
48. Selva-O'Callaghan A, Ordi-Ros J, Monegal-Ferran F, Martinez N, Cortes-Hernandez F, Vilardell-Tarres M (1998) IgA anticardiolipin antibodies- Relation with other antiphospholipid antibodies and clinical significance. Thromb Haemost 79:282-285
49. Yamada H, Tsutsumi A, Ichikawa K, Kato EH, Koike T, Fujimoto S (1999) IgA-class anti-beta2-glycoprotein I inwomen with unexplained recurrent spontaneous abortion. Arthritis Rheum 42:2727-2728
50. Lee RM, Branch DW, Silver RM (2001) Immunoglobulin A anti-beta2- glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 185:748-753
51. Lee RM, Emlen W, Scott JR, Branch DW, Silver RM (1999) Anti-beta2-glycoprotein-I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 181:642-648
52. Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR (2003) Values of IgA anticardiolipin and anti-β2-Glycoprotein I antibody testing in pateints with pregnancy morbidity. Ann Rheum Dis 62:540-543
53. Krause I, Blank M, Fraser A, Lorber M, Stojanovich L, Rovensky J et al (2005) The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 210:749-754
54. Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H et al (1985) Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59:231-234
55. Galli M, Finazzi G, Barbui T (1996) Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical revelance and treatment. Ann Med Interne (Paris) 147(Suppl 1):24-27
56. Bidot CJ, Jy W, Horstman LL, Ahn ER, Jimenez JJ, Yaniz M et al (2005) Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Haematol 128:366-372
57. Biasiolo A, Pengo V (1993) Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis. Blood Coagul Fibrinolysis 4:425-428
58. Godeau B, Piette JC, Fromont P, Intrator L, Schaeffer A, Bierling P (1997) Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol 98:873-879
59. Zwaal RF, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid assymmetry in blood cells. Blood 89:1121-1132
60. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S et al (1996) Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 39:1466-1474
61. Voss A, Jacobsen S, Heegaard NH (2001) Association of beta2-glycoprotein-I IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 10:533-538
62. Teixido M, Font J, Reverter JC, Cervera R, Tassies D, Ingelmo M et al (1997) A useful marker for the antiphospholipid syndrome. Br J Rheumatol 36:113-116
63. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC (1998) Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: Clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol 25:667-674
64. George J, Gilburd B, Langevitz P, Levy Y, Nezlin R, Harats D et al (1999) Beta-2 glycoprotein-I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels. Lupus 8:116-120
65. D'Cruz DP (2005) Autoantibodies to 2-glycoprotein-I in systemic lupus erythematosus anBetaRenal manifestations of the antiphospholipid syndrome. Lupus 14:45-48
66. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50:2569-2579
67. Loizou S, Samarkos M, Norsworthy PJ, Cazabon JK, Walport MJ, Davies KA (2000) Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis. Rheumatology (Oxford) 39:962-968
68. Vaidya S, Daller J, Gugliuzza K (2002) Role of anti-beta 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome. Clin Transplant 16:362-367
69. Tenedios F, Erkan D, Lockshin MD (2005) Cardiac involvement in the antiphospholipid syndrome. Lupus 14:691-696
70. Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A et al (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5:196-205
71. Afek A, Shoenfeld Y, Manor R, Goldberg I, Ziporen L, George J et al (1999) Increased endothelial cell expression of alpha3 beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus 8:502-507
72. Blank M, Krause I, Magrini L, Spina G, Kalil J, Jacobsen S et al (2006) Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) 45:833-841
73. Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA et al (2003) Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental study. Lupus 12:514-517
74. Miesbach W, Gilzinger A, Gokpinar B, Claus D, Scharrer I (2006) Prevalence of antiphospholipid antibodies in patients with neurolgical symptoms. Clin Neurol Neurosurg 108:135-142
75. Shrivastava A, Dwivedi S, Aggarwal A, Misra R (2001) Anticardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus 10:45-50
76. Weder-Cisneros ND, Tellez-Zenteno JF, Cardiel MH, Guibert-Toledano M, Cabiedes J, Velasquez-Paz AL et al (2004) Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Cephalalgia 24:1031-1044
77. Frances C, Niang S, Laffitte E, Pelletier F, Costedoat N, Piette JC (2005) Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 52:1785-1793
78. Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M et al (1993) Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 52:219-222